Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them. She also discusses the relatively slow pace of adoption of biosimilars in the U.S., the impact of innovative payment models on the marketplace, and the value that generics represent.
Video Forum: Christine Baeder, Teva USA

Latest

Circana forecasts continued U.S. food and beverage resilience
“The CPG industry must strategically identify ways to stimulate demand and remain profitable.”

Dollar General Literacy Foundation awards $3.5 million in youth literacy grants
The grants will fund professional development and buy books, technology, equipment, and other materials to support K-12 literacy programs.

Instacart names Etsy CEO Josh Silverman to Board of Directors
“I’m honored to join Instacart’s Board of Directors at such a pivotal moment for the company,” said Silverman.

C-stores expand East Coast footprint
Buc-ee’s, Wawa, QuickChek, and Arko Corp. add new locations across multiple states